Internal Standards: Rationale for Use in a Drug Utilization Review Program

1981 ◽  
Vol 15 (10) ◽  
pp. 789-792
Author(s):  
Stephen L. Huber ◽  
Roland A. Patry

The comparison of drug usage data gathered from different institutions would be easier if standardized criteria were employed. There are, however, major difficulties encountered in gaining approval of such criteria from different physician groups. To facilitate the criteria approval process, “internal standards” were developed. These internal standards reflected the acceptable deviations from the standardized criteria, hence, permitting flexibility for innovation in drug therapy. A retrospective drug utilization review was conducted in two hospitals. The internal standards assigned were very similar to the 0 percent-100 percent standards recommended by InterQuar® except for the criteria on monitoring parameters and duration of therapy. It would appear from these preliminary results that the assignment of internal standards enhances the use of standardized criteria which, in turn, will allow comparisons of data.

1978 ◽  
Vol 12 (12) ◽  
pp. 704-711 ◽  
Author(s):  
Jesse E. Stewart ◽  
James K. Marttila ◽  
Hugh F. Kabat ◽  
Albert I. Wertheimer

A discussion of one system designed for monitoring drug therapy in skilled nursing facility (SNF) patients is presented. This system will enable the pharmacist to fulfill the federal requirement for monitoring drug therapy and will provide the opportunity for gathering and analyzing drug usage data in fulfillment of the facility's utilization review requirement. The system described was developed and tested at five SNF's. Follow-up studies at each of the five facilities were then performed for comparison purposes. The data presented describe and analyze the results from both studies for two of the ten drugs studied: Digoxin and hydrochlorothiazide. The high rates of nonconformance to the established criteria are discussed and specific insights as to why drug therapy in these patients often seems inappropriate are provided.


2012 ◽  
Vol 29 (3) ◽  
pp. 264-270
Author(s):  
김태희 ◽  
윤은형 ◽  
Jong Hee Ko ◽  
손은선 ◽  
김성은 ◽  
...  

2020 ◽  
Vol 11 (3) ◽  
pp. 4095-4098
Author(s):  
Philip Jacob ◽  
Arul Balasubramanian ◽  
Kothai Ramalingam

Drug Utilization is also known as Drug Utilization Review, is an arrangement of persistent, orderly, criteria based medication assessment that guarantees the proper usage of drugs. Drug use/ utilization evaluation and medication utilization evaluations are the same as drug utilization review. It is a technique for acquiring data to recognize the problems related to the usage of drugs and if appropriately created, it also gives a method for revising the issue and in this way, it becomes a factor in reasonable drug usage. Evaluation of use can survey the real procedure of medication administration or dispensing of proper medication and furthermore the results of treatment. Drug utilization review services include corrective actions, prescriber reviews and further evaluations as a quality assurance mechanism. This article reviews the drug utilization pattern and evaluation of the process of drug utilization. The evaluation pattern can be classified into several categories such as prospective, concurrent and retrospective. The drug utilization evaluation process is a continuous cycle and its maximum effect is attained when it is conducted as a cycle rather than conducting in steps. This evidence-based approach with utilization of the medication is intended to depend on the best accessible clinical evidence to create explicit rules for a particular illness or utilization of a particular medication.


1992 ◽  
Vol 5 (2) ◽  
pp. 82-85
Author(s):  
Thomas A. Kellenberger

Communication about drug selection and use between physicians and pharmacists has changed in the last two decades. The enhanced clinical education offered to pharmacists and the recognition by many physicians that keeping up with advances in drug therapy is exceedingly difficult and time consuming has facilitated the change. Accordingly, hospitals and long-term care facilities have formalized the clinical role of the pharmacist in drug selection, use, and/or monitoring through the use of drug utilization review (DUR) programs, specifically called drug use evaluation (DUE) and drug regimen review (DRR), respectively, in these environments. A majority of drug therapy decisions, however, occur outside of these closed environments where the physician's drug information is often provided by representatives of the pharmaceutical manufacturers and where comprehensive DUR programs are in their infancy. As a source of information on drug products available from their company, sales representatives perform a valuable service, but their information, understandably, is focused on the advantages of their products. Making appropriate choices from alternative therapies that are more plentiful, complex and expensive than ever requires the physician to have access to current, scientifically valid, objective and unbiased information. Building on the value inherent in concurrent and retrospective DUR programs and on research conducted in the early 1980s, Medco Containment Services has developed a program that brings this type of prescribing information directly to physicians in their offices. Called the Optimal Therapeutics ProgramSM (OTPSM), Medco's program is fully operational in the Commonwealth of Massachusetts and is the vehicle for bringing clinically relevant, objective, and cost-effective prescribing information to physicians for application in the ambulatory care marketplace. This innovative program augments concurrent and retrospective DUR, delivering truly comprehensive DUR services. OTP also provides an opportunity for highly motivated and skilled pharmacists to shape their emerging role as drug information consultants.


1982 ◽  
Vol 16 (4) ◽  
pp. 199-202 ◽  
Author(s):  
M. Lee Morse ◽  
Aida A. Leroy ◽  
Thomas A. Gaylord ◽  
Thomas Kellenberger

2021 ◽  
Vol 13 (5) ◽  
pp. 520-525
Author(s):  
Vasudha Gupta ◽  
Jamie Woodyard ◽  
Kimberley Begley ◽  
Stacey Curtis ◽  
Deanna Tran

Sign in / Sign up

Export Citation Format

Share Document